DaVita
- Market cap
- 11.28B
- P/E (TTM)i
- 14.57
- P/Bi
- -14.74
- EPSi
- 9.84
- Div yieldi
- 0.00%
- 52W posi
- 52%
Anonymous reader poll. Unscientific, not investment advice.
About DaVita
DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
- Founded
- 1994
- CEO
- Mr. Javier J. Rodriguez
- Employees
- 78,000
- Headquarters
- Denver, Colorado, United States of America
- Fiscal year end
- 12-31
- Website
- davita.com
Company profile
- Exchange
- US
- Symbol
- DVA
- Market-cap rank
- #1361
- Listing date
- 1970-01-01
- Market cap
- 11.28B
- Float cap
- 6.00B
- Shares out
- 63.80M
- Float shares
- 33.94M
Sectors & themes
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.